Gender differences in cancer susceptibility: An inadequately addressed issue

Frontiers in Genetics

Volumn 3, Issue NOV, 2012, Pages 1-11

  Tevfik Dorak, M ^a   Karpuzoglu, Ebru ^b  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Cancer susceptibility; Genetic epidemiology; Genetic predisposition to disease; Sex chromosomes; Sex factors; Sex hormones

Indexed keywords

EID: 84876090560     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2012.00268     Document Type: Article

References (128)

1. Arnold, A. P., and Burgoyne, P. S. (2004). Are XX and XY brain cells intrinsically different? Trends Endocrinol. Metab. 15,6-11.
2. Arnold, A. P., and Lusis, A. J. (2012). Understanding the sexome: measuring and reporting sex differences in gene systems. Endocrinology 153, 2551-2555.
3. Arnold, K. (2000). Journal to encourage analysis by sex/ethnicity. J. Natl. Cancer Inst. 92, 1561.
4. Ashley, D. J. (1969). A male-female differential in tumour incidence. Br. J. Cancer 23,21-25.
5. Berghofer, B., Frommer, T., Haley, G., Fink, L., Bein, G., and Hackstein, H. (2006). TLR7 ligands induce higher IFN-alpha production in females. J. Immunol. 177,2088-2096.
6. Bermejo-Alvarez, P., Rizos, D., Lonergan, P., and Gutierrez-Adan, A. (2011). Transcriptional sexual dimorphism during preimplantation embryo development and its consequences for developmental competence and adult health and disease. Reproduction 141, 563-570.
7. Bianchi, I., Lleo, A., Gershwin, M. E., and Invernizzi, P. (2012). The X chromosome and immune associated genes. J. Autoimmun. 38, J187-J192.
8. Biggar, R. J., Bergen, A. W., and Poulsen, G. N. (2009). Impact of X chromosome genes in explaining the excess risk of cancer in males. Am. J. Epidemiol. 170,65-71.
9. Blaustein, J. D. (2012). Animals have a sex, and so should titles and methods sections of articles in endocrinology. Endocrinology 153,2539-2540.
10. Bollati, V., and Baccarelli, A. (2010). Environmental epigenetics. Heredity 105, 105-112.
11. Bond, G. L., Hirshfield, K. M., Kirchhoff, T., Alexe, G., Bond, E. E., Robins, H., et al. (2006). MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner. Cancer Res. 66,5104-5110.
12. Brait, M., Ford, J. G., Papaiahgari, S., Garza, M. A., Lee, J. I., Loyo, M., et al. (2009). Association between lifestyle factors and CpG island methylation in a cancer-free population. Cancer Epidemiol. Biomarkers Prev. 18, 2984-2991.
13. Broman, K. W., Murray, J. C., Sheffield, V. C., White, R. L., and Weber, J. L. (1998). Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am. J. Hum. Genet. 63, 861-869.
14. Carrel, L., and Willard, H. F. (2005). X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434, 400-404.
15. Cartwright, R. A., Gurney, K. A., and Moorman, A. V. (2002). Sex ratios and the risks of haematological malignancies. Br. J. Haematol. 118, 1071-1077.
16. Clodfelter, K. H., Holloway, M. G., Hodor, P., Park, S. H., Ray, W J., and Waxman, D. J. (2006). Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol. Endocrinol. 20, 1333-1351.
17. Conforto, T. L., and Waxman, D. J. (2012). Sex-specific mouse liver gene expression: genome-wide analysis of developmental changes from pre-pubertal period to young adulthood. Biol Sex Differ. 3,9.
18. Cook, M. B., Dawsey, S. M., Freedman, N. D., Inskip, P. D., Wichner, S. M., Quraishi, S. M., et al. (2009). Sex disparities in cancer incidence by period and age. Cancer Epidemiol. Biomarkers Prev. 18,1174-1182.
19. Cook, M. B., McGlynn, K. A., Devesa, S. S., Freedman, N. D., and Anderson, W F. (2011). Sex disparities in cancer mortality and survival. Cancer Epidemiol. Biomarkers Prev. 20, 1629-1637.
20. Cookson, W., Liang, L., Abecasis, G., Moffatt,M.,andLathrop,M. (2009). Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 10,184-194.
21. Cramer, D. W., and Finn, O. J. (2011). Epidemiologic perspective on immune-surveillance in cancer. Curr. Opin. Immunol. 23, 265-271.
22. Dai, R., Phillips, R. A., Zhang, Y., Khan, D., Crasta, O., and Ahmed, S. A. (2008). Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 112,4591-4597.
23. Damian, D. L., Patterson, C. R., Stapelberg, M., Park, J., Barnetson, R. S., and Halliday, G. M. (2008). UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. J. Invest. Dermatol. 128,447-454.
24. Desandes, E., Clavel, J., Berger, C., Bernard, J. L., Blouin, P., De Lumley, L., et al. (2004). Cancer incidence among children in France, 1990-1999. Pediatr Blood Cancer 43, 749-757.
25. Devarahally, S. R., Severson, R. K., Chuba, P., Thomas, R., Bhambhani, K., and Hamre, M. R. (2003). Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence. Pediatr. Hematol. Oncol. 20, 617-625.
26. Do, T. N., Ucisik-Akkaya, E., Davis, C. E, Morrison, B. A., and Dorak, M. T. (2009). TP53 R72P and MDM2 SNP309 polymorphisms in modification of childhood acute lymphoblastic leukemia susceptibility. Cancer Genet. Cytogenet. 195,31-36.
27. Do, T. N., Ucisik-Akkaya, E., Davis, C. F., Morrison, B. A., and Dorak, M. T. (2010). An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males. Biochim. Biophys. Acta 1802, 292-300.
28. Duma, D., Collins, J. B., Chou, J. W., and Cidlowski, J. A. (2010). Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence. Sci. Signal. 3, ra74.
29. Eden, O. B., Harrison, G., Richards, S., Lilleyman, J. S., Bailey, C. C., Chessells, J. M., et al. (2000). Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party. Leukemia 14, 2307-2320.
30. Edgren, G., Liang, L., Adami, H. O., and Chang, E. T. (2012). Enigmatic sex disparities in cancer incidence. Eur. I Epidemiol. 27, 187-196.
31. El-Maarri, O., Becker, T., Junen, J., Manzoor, S. S., Diaz-Lacava, A., Schwaab, R., et al. (2007). Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males. Hum. Genet. 122,505-514.
32. Eyles, J., Puaux, A. L., Wang, X., Toh, B., Prakash, C., Hong, M., et al. (2010). Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J. Clin. Invest. 120, 2030-2039.
33. Fish, E. N. (2008). The X-files in immunity: sex-based differences predispose immune responses. Nat. Rev. Immunol. 8, 737-744.
34. Fisher, S. A., Hampe, J., Macpherson, A. J., Forbes, A., Lennard-Jones, J. E., Schreiber, S., et al. (2002). Sex stratification of an inflammatory bowel disease genome search shows male-specific linkage to the HLA region of chromosome 6. Eur. J. Hum. Genet. 10,259-265.
35. Foley, D. L., Craig, J. M., Morley, R., Olsson, C. A., Dwyer, T., Smith, K., et al. (2009). Prospects for epigenetic epidemiology. Am. J. Epidemiol. 169, 389-400.
36. Gabory, A., Attig, L., and Junien, C. (2009). Sexual dimorphism in environmental epigenetic programming. Mol. Cell. Endocrinol. 304, 8-18.
37. Ghazeeri, G., Abdullah, L., and Abbas, O (2011). Immunological differ ences in women compared with men: overview and contributing fac tors. Am. J. Reprod. Immunol. 66, 163-169.
38. Giacomoni, P. U., Mammone, T., and Teri, M. (2009). Gender-linked differences in human skin. J. Dermatol. Sci. 55, 144-149.
39. Gold, B., Bergeron, J., Lachtermacher-Triunfol, M., and Dean, M. (2001). Human duplex sex determination PCR. Biotechniques 31, 28-30, 32,35.
40. Green, M. S. (1992). The male predominance in the incidence of infectious diseases in children: a postulated explanation for disparities in the literature. Int. J. Epidemiol. 21, 381-386.
41. Greenberg, R. S., and Shuster, J. L. Jr. (1985). Epidemiology of cancer in children. Epidemiol. Rev. 7,22-48.
42. Hattersley, A. T., and McCarthy, M. I (2005). What makes a good genetic association study? Lancet 366, 1315-1323.
43. Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., et al. (2007). Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 87, 905-931.
44. Hemminki, K., Lorenzo Bermejo, J., and Forsti, A. (2006). The balance between heritable and environmental etiology of human disease. Nat. Rev. Genet. 7, 958-965.
45. Hindorff, L. A., Sethupathy, P., Junkins, H. A., Ramos, E. M., Mehta, J. P., Collins, E S., et al. (2009). Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U.S.A. 106, 9362-9367.
46. Isensee, J., and Ruiz Noppinger, P. (2007). Sexually dimorphic gene expression in mammalian somatic tissue. Gend. Med. 4(Suppl. B), S75-S95.
47. Isensee, J., Witt, H., Pregla, R., Hetzer, R., Regitz-Zagrosek, V., and Noppinger, P. R. (2008). Sexually dimorphic gene expression in the heart of mice and men. J. Mol. Med. 86, 61-74.
48. Kalaitzidis, D., and Gilmore, T. D. (2005). Transcription factor crosstalk: the estrogen receptor and NF-kappaB. Trends Endocrinol. Metab. 16,46-52.
49. Kaminsky, Z., Wang, S. C., and Petronis,A. (2006). Complex disease, gender and epigenetics. Ann. Med. 38, 530-544.
50. Karpuzoglu, E., and Zouali, M. (2011). The multi-faceted influences of estrogen on lymphocytes: toward novel immunointerventions strategies for autoimmunity management. Clin. Rev. Allergy Immunol. 40, 16-26.
51. Kato, S., Sato, T., Watanabe, T., Takemasa, S., Masuhiro, Y., Ohtake, F., et al. (2005). Function of nuclear sex hormone receptors in gene regulation. Cancer Chemother. Pharmacol. 56(Suppl. 1), 4-9.
52. Kirsch-Volders, M., Bonassi, S., Herceg, Z., Hirvonen, A., Moller, L., and Phillips, D. H. (2010). Gender-related differences in response to mutagens and carcinogens. Mutagenesis 25,213-221.
53. Kiyohara, C., and Ohno, Y. (2010). Sex differences in lung cancer susceptibility: a review. Gend. Med. 7, 381-401.
54. Klein, S. L. (2000). The effects of hormones on sex differences in infection: from genes to behavior. Neurosci. Biobehav. Rev. 24, 627-638.
55. Klein, S. L. (2012). Immune cells have sex and so should journal articles. Endocrinology 153,2544-2550.
56. Klein, S. L., Hodgson, A., and Robinson, D. P. (2012). Mechanisms of sex disparities in influenza pathogenesis. J. Leukoc. Biol. 92, 67-73.
57. Kong, A., Thorleifsson, G., Stefansson, H., Masson, G., Helgason, A., Gudbjartsson, D. F., et al. (2008). Sequence variants in the RNF212 gene associate with genome-wide recombination rate. Science 319, 1398-1401.
58. Kovats, S. (2012). Estrogen receptors regulate an inflammatory pathway of dendritic cell differentiation: mechanisms and implications for immunity. Horm. Behav. 62, 254-262.
59. Lawrence, T., Hageman, T., and Balkwill, F. (2007). Sex, cytokines, and cancer. Science 317, 51-52.
60. Le Marchand, L. (2005). The predominance of the environment over genes in cancer causation: implications for genetic epidemiology. Cancer Epidemiol. Biomarkers Prev. 14, 1037-1039.
61. Lee, M. L., Chen, G. G., Vlantis, A. C., Tse, G. M., Leung, B. C., and Van Hasselt, C. A. (2005). Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of BclxL. CancerJ. 11, 113-121.
62. Li, Y., Breitling, R., and Jansen, R. C. (2008). Generalizing genetical genomics: getting added value from environmental perturbation. Trends Genet. 24, 518-524.
63. Libert, C., Dejager, L., and Pinheiro, I. (2010). The X chromosome in immune functions: when a chromosome makes the difference. Nat. Rev. Immunol. 10, 594-604.
64. Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo,M., etal. (2000). Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78-85.
65. Lin, A. A., Wojciechowski, S. E., and Hildeman, D. A. (2010). Androgens suppress antigen-specific T cell responses and IFN-gamma production during intracranial LCMV infection. J. Neuroimmunol. 226, 8-19.
66. Linet, M. S., and Devesa, S. S. (1991). Descriptive epidemiology of childhood leukemia. Br. J. Cancer 63, 424-429.
67. Lista, P., Straface, E., Brunelleschi, S., Franconi, F., and Malorni, W. (2011). On the role of autophagy in human diseases: a gender perspective. J. Cell. Mol. Med. 15,1443-1457.
68. Liu, L. Y., Schaub, M. A., Sirota, M., and Butte, A. J. (2012). Sex differences in disease risk from reported genome-wide association study findings. Hum. Genet. 131,353-364.
69. Loisel, D. A., Tan, Z., Tisler, C. J., Evans, M. D., Gangnon, R. E., Jackson, D. J., et al. (2011). IFNG genotype and sex interact to influence the risk of childhood asthma. J. Allergy Clin. Immunol. 128,524-531.
70. Mank, J. E., Nam, K., Brunstrom, B., and Ellegren, H. (2010). Ontogenetic complexity of sexual dimorphism and sex-specific selection. Mol. Biol. Evol. 27, 1570-1578.
71. Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., et al. (2009). Finding the missing heritability of complex diseases. Nature 461, 747-753.
72. Martin, J. T. (2000). Sexual dimorphism in immune function: the role of prenatal exposure to androgens and estrogens. Eur. J. Pharmacol. 405, 251-261.
73. Mittelstrass, K., Ried, J. S., Yu, Z., Krumsiek, J., Gieger, C., Prehn, C., et al. (2011). Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet. 7, e1002215. doi:10.1371/journal.pgen.1002215
74. Molife, R., Lorigan, P., and Macneil, S. (2001). Gender and survival in malignant tumours. Cancer Treat. Rev. 27,201-209.
75. Morris, J. A., and Harrison, L.M. (2009). Hypothesis: increased male mortality caused by infection is due to a decrease in heterozygous loci as a result of a single X chromosome. Med. Hypotheses 72, 322-324.
76. Murphy, A., Chu, J. H., Xu, M., Carey, V. J., Lazarus, R., Liu, A., et al. (2010). Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes. Hum. Mol. Genet. 19,4745-4757.
77. Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M.,etal. (2007). Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121-124.
78. Nica, A. C., and Dermitzakis, E. T. (2008). Using gene expression to investigate the genetic basis of complex disorders. Hum. Mol. Genet. 17, R129-R134.
79. Nick, T. G., and Campbell, K. M. (2007). Logistic regression. Methods Mol. Biol. 404,273-301.
80. Ober, C., Loisel, D. A., and Gilad, Y. (2008). Sex-specific genetic architecture of human disease. Nat. Rev. Genet. 9,911-922.
81. Olsen, N. J., and Kovacs, W J. (1996). Gonadal steroids and immunity. Endocr. Rev. 17, 369-384.
82. Ostrer, H. (2001). Invited review: sex-based differences in gene expression. J. Appl. Physiol. 91, 2384-2388.
83. Palaszynski, K. M., Smith, D. L., Kamrava, S., Burgoyne, P. S., Arnold, A. P., and Voskuhl, R. R. (2005). A yin-yang effect between sex chromosome complement and sex hormones on the immune response. Endocrinology 146, 3280-3285.
84. Patsopoulos, N. A., Tatsioni, A., and Ioannidis, J. P. (2007). Claims of sex differences: an empirical assessment in genetic associations. JAMA 298, 880-893.
85. Paul, S. R., and Donner, A. (1989). A comparison of tests of homogeneity of odds ratios in K 2x2 tables. Stat. Med. 8,1455-1468.
86. Pearce, M. S., and Parker, L. (2001). Childhood cancer registrations in the developing world: still more boys than girls. Int. J. Cancer 91,402-406.
87. Penaloza, C., Estevez, B., Orlanski, S., Sikorska, M., Walker, R., Smith, C., et al. (2009). Sex of the cell dictates its response: differential gene expression and sensitivity to cell death inducing stress in male and female cells. FASEBJ. 23, 1869-1879.
88. Pennell, L. M., Galligan, C. L., and Fish, E. N. (2012). Sex affects immunity. J. Autoimmun. 38, J282-J291.
89. Pinheiro, I., Dejager, L., and Libert, C. (2011). X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females. Bioessays 33, 791-802.
90. Purtilo, D. T., and Sullivan, J. L. (1979). Immunological bases for superior survival of females. Am. J. Dis. Child. 133, 1251-1253.
91. Rahbari, R., Zhang, L., and Kebebew, E. (2010). Thyroid cancer gender disparity. Future. Oncol. 6, 1771-1779.
92. Read, J. S., Troendle, J. F., and Klebanoff, M. A. (1997). Infectious disease mortality among infants in the United States, 1983 through 1987. Am. J. PublicHealth 87, 192-198.
93. Reeve, V. E., Allanson, M., Domanski, D., and Painter, N. (2012). Gender differences in UV-induced inflammation and immunosuppression in mice reveal male unresponsiveness to UVA radiation. Photochem. Photobiol.Sci. 11, 173-179.
94. Relton, C. L., and Davey Smith, G. (2010). Epigenetic epidemiology of common complex disease: prospects for prediction, prevention, and treatment. PLoS Med. 7, e1000356. doi:10.1371/journal.pmed.1000356
95. Rice, T. K., Schork, N. J., and Rao, D. C. (2008). Methods for handling multiple testing. Adv. Genet. 60, 293-308.
96. Ries, L. A. G., Smith, M. A., Gurney, J. G., Linet, M., Tamra, T., Young, J. L., et al. (eds). (1999). Cancer Incidence and Survival Among Children and Adolescents: Unites States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute, SEER Program.
97. Rinn, J. L., Rozowsky, J. S., Laurenzi, I. J., Petersen, P. H., Zou, K., Zhong, W., et al. (2004). Major molecular differences between mammalian sexes are involved in drug metabolism and renal function. Dev. Cell 6, 791-800.
98. Rinn, J. L., and Snyder, M. (2005). Sexual dimorphism in mammalian gene expression. Trends Genet. 21, 298-305.
99. Sader, M. A., McGrath, K. C., Hill, M. D., Bradstock, K. F., Jimenez, M., Handelsman, D. J., et al. (2005). Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis. Clin. Endocrinol. (Oxf.) 62, 56-63.
100. Scheller, A., Hughes, E., Golden, K. L., and Robins, D. M. (1998). Multiple receptor domains interact to permit, or restrict, androgen-specific gene activation. J. Biol. Chem. 273, 24216-24222.
101. Schlegel, R. J., and Bellanti, J. A. (1969). Increased susceptibility of males to infection. Lancet 2, 826-827.
102. Schonfeld, S. J., Neta, G., Sturgis, E. M., Pfeiffer, R. M., Hutchinson, A. A., Xu, L., et al. (2012). Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk. Thyroid 22, 151-156.
103. Schroder, J., Kahlke, V., Book, M., and Stuber, E (2000). Gender differences in sepsis: genetically determined? Shock 14, 307-310; discussion 310-303.
104. Shifman, S., Johannesson, M., Bronstein, M., Chen, S. X., Collier, D. A., Craddock, N. J., et al. (2008). Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet. 4, e28. doi:10.1371/journal.pgen.0040028
105. Shriver, S. P., Bourdeau, H. A., Gubish, C. T., Tirpak, D. L., Davis, A. L., Luketich, J. D., et al. (2000). Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J. Natl. Cancer Inst. 92, 24-33.
106. Siegel, R., Naishadham, D., and Jemal, A. (2012). Cancer statistics, 2012. CA Cancer J. Clin. 62, 10-29.
107. Siontis, K. C., Patsopoulos, N. A., and Ioannidis, J. P. (2010). Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies. Eur. J. Hum. Genet. 18, 832-837.
108. Smith-Bouvier, D. L., Divekar, A. A., Sasidhar, M., Du, S., Tiwari-Woodruff, S. K., King, J. K., et al. (2008). A role for sex chromosome complement in the female bias in autoimmune disease. J. Exp. Med. 205, 1099-1108.
109. Spitz, M. R., Sider, J. G., Johnson, C. C., Butler, J. J., Pollack, E. S., and Newell, G. R. (1986). Ethnic patterns of Hodgkin's disease incidence among children and adolescents in the United States, 1973-82. J. Natl. Cancer Inst. 76,235-239.
110. Stanley, J. A., Aruldhas, M. M., Chan-drasekaran, M., Neelamohan, R., Suthagar, E., Annapoorna, K., et al. (2012). Androgen receptor expression in human thyroid cancer tissues: a potential mechanism underlying the gender bias in the incidence of thyroid cancers. J. Steroid Biochem. Mol. Biol. 130, 105-124.
111. Streilein, J. W., Taylor, J. R., Vincek, V., Kurimoto, I., Richardson, J., Tie, C., et al. (1994). Relationship between ultraviolet radiation-induced immunosuppression and carcinogenesis. J. Invest. Dermatol. 103, 107S-111S.
112. Swann, J. B., and Smyth, M. J. (2007). Immune surveillance of tumors. J. Clin. Invest. 117,1137-1146.
113. Thomas, D. (2010). Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies. Annu. Rev. Public Health 31, 21-36.
114. Tobi, E. W., Lumey, L. H., Talens, R. P., Kremer, D., Putter, H., Stein, A. D., et al. (2009). DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum. Mol. Genet. 18, 4046-4053.
115. Vaissiere, T., Hung, R. J., Zaridze, D., Moukeria, A., Cuenin, C., Fasolo, V., et al. (2009). Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res. 69,243-252.
116. van Nas, A., Guhathakurta, D., Wang, S. S., Yehya, N., Horvath, S., Zhang, B., et al. (2009). Elucidating the role of gonadal hormones in sexually dimorphic gene coexpression networks. Endocrinology 150, 1235-1249.
117. Washburn, T. C., Medearis, D. N. Jr., and Childs, B. (1965). Sex differences in susceptibility to infections. Pediatrics 35, 57-64.
118. Waterland, R. A., Kellermayer, R., Laritsky, E., Rayco-Solon, P., Harris, R. A., Travisano, M., et al. (2010). Season of conception in rural Gambia affects DNA methylation at putative human metastable epialleles. PLoS Genet. 6, e1001252. doi:10.1371/journal.pgen.1001252
119. Waxman, D. J., and Holloway, M. G. (2009). Sex differences in the expression of hepatic drug metabolizing enzymes. Mol. Pharmacol. 76, 215-228.
120. Weige, C. C., Allred, K. F., and Allred, C. D. (2009). Estradiol alters cell growth in nonmalignant colonocytes and reduces the formation of preneoplastic lesions in the colon. Cancer Res. 69,9118-9124.
121. Weiss, L. A., Pan, L., Abney, M., and Ober, C. (2006). The sex-specific genetic architecture of quantitative traits in humans. Nat. Genet. 38, 218-222.
122. Wells, J. C. (2000). Natural selection and sex differences in morbidity and mortality in early life. J. Theor. Biol. 202, 65-76.
123. Wijchers, P. J., and Festenstein, R. J. (2011). Epigenetic regulation of autosomal gene expression by sex chromosomes. Trends Genet. 27, 132-140.
124. Yang, X., Schadt, E. E., Wang, S., Wang, H., Arnold, A. P., Ingram-Drake, L., et al. (2006). Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 16, 995-1004.
125. Yeh, S. H., and Chen, P. J. (2010). Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology 78(Suppl. 1), 172-179.
126. Yuasa, Y. (2010). Epigenetics in molecular epidemiology of cancer a new scope. Adv. Genet. 71,211-235.
127. Zahm, S. H., and Fraumeni, J. F. Jr. (1995). Racial, ethnic, and gender variations in cancer risk: considerations for future epidemiologic research. Environ. Health Perspect. 103(Suppl. 8), 283-286.
128. Zhang, Y., Klein, K., Sugathan, A., Nassery, N., Dombkowski, A., Zanger, U. M., et al. (2011). Transcriptional profiling of human liver identifies sex-biased genes associated with polygenic dyslipidemia and coronary artery disease. PLoS ONE 6, e23506. doi:10.1371/journal.pone.0023506.